Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

22.10
Delayed Data
As of 4:02pm ET
 -0.60 / -2.64%
Today’s Change
8.31
Today|||52-Week Range
24.43
+6.35%
Year-to-Date
Jeff Ubben: The Friendly Activist
Dec 31 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close22.70
Today’s open22.56
Day’s range21.54 - 22.63
Volume12,920,639
Average volume (3 months)15,447,520
Market cap$7.9B
Data as of 4:02pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)-716.47%
Earnings growth (this year)-30.40%
Earnings growth (next 5 years)+3.50%
Revenue growth (last year)-7.39%
P/E ratio5.7
Price/Sales0.52
Price/Book2.50

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV-0.25-0.23%
CTLTCatalent Inc-0.63-1.46%
ACADACADIA Pharmaceutica...-0.47-1.66%
TAROTaro Pharmaceutical ...+1.96+1.86%
Data as of 4:02pm ET, 01/18/2018

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)$0.96
Annual revenue (last year)$9.7B
Annual profit (last year)-$2.4B
Net profit margin-24.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts